Click Here for 5% Off Your First Aladdin Purchase!

VX-809 (Lumacaftor) - ≥98%, high purity , Cystic fibrosis transmembrane conductance regulator stabiliser, CAS No.936727-05-8, Cystic fibrosis transmembrane conductance regulator stabiliser

  • Moligand™
  • ≥98%
Item Number
V127916
Grouped product items
SKUSizeAvailabilityPrice Qty
V127916-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$53.90
V127916-10mg
10mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$75.90
V127916-50mg
50mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$118.90

Basic Description

SynonymsLumacaftor|936727-05-8|VX-809|VX809|VX 809|3-(6-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid|VRT-826809|VRT 826809|VX-809 (Lumacaftor)|EGP8L81APK|3-(6-{[1-(2,2-Difluoro-benzo[1,3]dioxol-5-yl)-cyclopro
Specifications & Purity≥98%
Storage TempStore at -20°C
Shipped InDry ice
GradeMoligand™
Action TypeSTABILISER
Mechanism of actionCystic fibrosis transmembrane conductance regulator stabiliser
Product Description

VX-809 (Lumacaftor) acts to correct CFTR mutations common in cystic fibrosis by increasing mutant CFTR (F508del-CFTR) maturation,EC50 of 0.1 μM.

Product Properties

ALogP4.4

Associated Targets

CFTR Tclin Cystic fibrosis transmembrane conductance regulator 4 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 3-[6-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-3-methylpyridin-2-yl]benzoic acid
INCHI InChI=1S/C24H18F2N2O5/c1-13-5-8-19(27-20(13)14-3-2-4-15(11-14)21(29)30)28-22(31)23(9-10-23)16-6-7-17-18(12-16)33-24(25,26)32-17/h2-8,11-12H,9-10H2,1H3,(H,29,30)(H,27,28,31)
InChi Key UFSKUSARDNFIRC-UHFFFAOYSA-N
Canonical SMILES CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O
Isomeric SMILES CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O
PubChem CID 16678941
Molecular Weight 452.41

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

1 results found

Lot NumberCertificate TypeDateItem
F1524095Certificate of AnalysisJan 24, 2023 V127916

Chemical and Physical Properties

SolubilityDMSO 91 mg/mL Water <1 mg/mL Ethanol 6 mg/mL

Safety and Hazards(GHS)

Pictogram(s) GHS06,   GHS08,   GHS05,   GHS07
Signal Danger
Hazard Statements

H301:Toxic if swallowed

H318:Causes serious eye damage

H312:Harmful in contact with skin

H372:Causes damage to organs through prolonged or repeated exposure

H360:May damage fertility or the unborn child

Precautionary Statements

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P270:Do not eat, drink or smoke when using this product.

P362+P364:Take off contaminated clothing and wash it before reuse.

P330:Rinse mouth.

P203:Obtain, read and follow all safety instructions before use.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P301+P316:IF SWALLOWED: Get emergency medical help immediately.

P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing.

P318:if exposed or concerned, get medical advice.

P317:Get emergency medical help.

P319:Get medical help if you feel unwell.

Related Documents

References

1. Okiyoneda T, Veit G, Dekkers JF, Bagdany M, Soya N, Xu H, Roldan A, Verkman AS, Kurth M, Simon A et al..  (2013)  Mechanism-based corrector combination restores ΔF508-CFTR folding and function..  Nat Chem Biol,  (7): (444-54).  [PMID:23666117]
2. Ren HY, Grove DE, De La Rosa O, Houck SA, Sopha P, Van Goor F, Hoffman BJ, Cyr DM.  (2013)  VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1..  Mol Biol Cell,  24  (19): (3016-24).  [PMID:23924900]
3. Fiedorczuk K, Chen J.  (2022)  Mechanism of CFTR correction by type I folding correctors..  Cell,  185  (1): (158-168.e11).  [PMID:34995514]

Solution Calculators